Your session is about to expire
← Back to Search
CCR2-Targeted Imaging for Pancreatic Cancer
Study Summary
This trial is testing a new way to find and treat pancreatic cancer by targeting a protein called CCR2 that is found on certain immune cells. If successful, this could help improve treatment for pancreatic cancer and reduce side effects.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My pancreatic cancer is advanced and I am scheduled for chemotherapy.I have advanced pancreatic cancer and am considering or have agreed to a specific therapy.I cannot stay still for 90 minutes during a scan.I am 18 or older with early-stage pancreatic cancer and scheduled for or have had chemotherapy before surgery.I have not had any cancer other than non-melanoma skin cancer in the past 5 years.I am not pregnant or nursing, and cannot become pregnant or am not currently pregnant.
- Group 1: Cohort 1a: Treatment Whipple/Surgical Procedure/Surgery following neoadjuvant therapy
- Group 2: Cohort 1b: Standard of Care Treatment Chemotherapy
- Group 3: Cohort 2: CCR2-Targeted Therapy
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any risks associated with utilizing 64Cu-DOTA-ECLIi for medicinal purposes?
"Due to its Phase 1 status, there are limited safety and efficacy data points on 64Cu-DOTA-ECLIi. Our team at Power has assessed that it is a 1 in terms of risk level."
Are there any vacancies for the current research project?
"Affirmative. The clinicaltrial.gov data shows that this research trial is actively enrolling participants, with the original posting date of January 2nd 2019 and most recent update occurring on May 23rd 2022. 75 individuals are required for the study at a single site."
To what magnitude is participation in this research endeavor?
"Affirmative. Information on clinicaltrials.gov affirms that this experiment is actively searching for participants, initially posted on January 2nd 2019 and most recently edited May 23rd 2022. It seeks to recruit 75 individuals from 1 site."
Share this study with friends
Copy Link
Messenger